Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter was issued to Kadesh International on May 2, 2019, regarding drug manufacturing or distribution operations. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulation and enforcement authority. To understand the specific compliance issues cited, review of the complete Warning Letter would be necessary.